Physiology and Pathophysiology in Ultra-Marathon Running
An overview of ultra-marathon physiology and pathophysiology. A typical ultra-marathoner is male, married, well-educated and ~45 years old; women account for ~20% of finishers. Ultra-marathoners are older and train with a larger weekly volume, but more slowly, than marathoners.
Previous experience (finishes in ultras, personal best marathon time) is the most important predictor of ultra performance, followed by anthropometry (low BMI, low body fat) and training (high volume and running speed in training). The sex difference has narrowed to ~10-20% depending on race length, and peak performance comes at 35-45 years or older, later for longer races.
An ultra causes an energy deficit that reduces body fat and skeletal muscle mass; with other risk factors (heat or cold, the host country) it can lead to exercise-associated hyponatremia. Biomarkers of muscle, heart, liver, kidney, immune and endocrine stress change, usually temporarily.
In longer ultras ~50-60% of participants have musculoskeletal problems, mostly at the ankle and knee; creatine kinase can reach 100,000-200,000 U/l. Digestive problems, gastrointestinal bleeding, a temporary fall in renal function and upper respiratory infections after the race are common.
Participants
Not applicable (review). The abstract does not give the number of studies reviewed.
Protocol
Key Results
| Topic | What the review reports |
|---|---|
| Typical participant | Male, married, well-educated, ~45 years old; women ~20% of finishers |
| Training vs marathoners | Older, larger weekly training volume, slower training pace |
| Strongest performance predictor | Previous experience (ultra finishes, personal best marathon time), then anthropometry (low BMI, low body fat) and training (high volume and speed) |
| Sex difference | Narrowed to ~10-20%, depending on race length |
| Age of fastest times | 35-45 years or older; rises with race distance or duration |
| Musculoskeletal problems (longer ultras) | ~50-60% of participants; mostly ankle and knee |
| Creatine kinase | Can reach 100,000-200,000 U/l, depending on fitness and race length |
| Other acute effects | Energy deficit (fat and muscle loss), hyponatremia risk, cardiac biomarker and imaging changes, liver enzyme rises, temporary fall in renal function, digestive problems and GI bleeding, upper respiratory infections |
Practical Application
Limitations
How this entry was checked and changed
narrative overview without systematic method; its figures are approximate ("~") and not traced to named studies in the abstract